BioNext

London, Ontariobionext.ca

Overview

BioNext is a MedTech incubator at Western University that accelerates the translation of early ideas to commercial innovations by providing access to infrastructure, a network of experts, and investor readiness support.

Portfolio Companies

Website

bionext.ca

Investments

BioNext investments
Company	Date	Stage	Lead
Vessl Prosthetics	Jan 2025	Pre Seed	Co-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium

SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium

2021

2022

2023

2024

2025

2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is BioNext based?

BioNext is headquartered in London, Ontario, Canada.

When was BioNext founded?

Founding year information for BioNext is not publicly available.

How many portfolio companies does BioNext have?

BioNext has 1 portfolio company in Caplight's dataset.

What are some companies in BioNext's portfolio?

Portfolio companies visible on Caplight include Vessl Prosthetics.

What was BioNext's most recent investment shown here?

BioNext's most recent investment in this portfolio sample was in Vessl Prosthetics in 2025.

What sectors does BioNext focus on?

BioNext focuses on Healthcare & Life Sciences, Frontier & Industrial Tech.

What company stages does BioNext focus on?

BioNext typically invests at the Early stage.

Firmographic Details

HeadquartersLondon, Ontario

Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?